Tumor-acidity and bioorthogonal chemistry-mediated construction and deconstruction of drug depots for ferroptosis under normoxia and hypoxia
Source abstract
Abstract
Mounting evidence shows that tumor hypoxia stress promotes tumor invasion and metastasis and induces therapeutic resistance. Oxygen-independent Fenton reaction, which refers to the iron-catalyzed conversion of endogenous hydrogen peroxide (H2O2) to hydroxyl radical (·OH), has been designed for ferroptosis therapy. Nevertheless, the treatment efficiency is compromised by limited H2O2 content and limited tumor retention and penetration of nanoparticles. Herein, we designed a tumor-acidity and bioorthogonal chemistry mediated construction and deconstruction of drug depots for tumor ferroptosis under normoxia and hypoxia. Briefly, the dendritic poly(amidoamine) (PAMAM, G4) was modified using cinnamaldehyde (CA) to deplete GSH and increase H2O2 levels, and ferrocene (Ferr) served as Fenton reaction catalyst to generate PFC. Subsequently, PFC was modified with maleic acid amide with slow pH-response rate and poly(2-azepane ethyl methacrylate) (PAEMA) with rapid pH-response rate, accompanied with highly efficient bioorthogonal chemistry to construct and deconstruct drug depots for enhanced tumor retention and penetration. The small-sized PFC potentially induced H2O2 self-supplied ferroptosis under normoxia and hypoxia. In sum, this work utilizes two tumoral acidity-responsive groups with different response rates and highly efficient bioorthogonal click chemistry, which paves a way for ferroptosis and provides a general drug delivery strategy with enhanced tumor retention and penetration. STATEMENT OF SIGNIFICANCE: Oxygen independent Fenton reaction refers to the conversion of endogenous H2O2 to ·OH which has been designed for ferroptosis therapy. Nevertheless, limited H2O2 level and abundant GSH in tumor cells could both compromise the treatment efficiency. Herein, we developed a tumor-acidity and bioorthogonal chemistry mediated construction and deconstruction of drug depots, which elevate the intracellular H2O2 level and deplete GSH for tumor ferroptosis under normoxia and hypoxia microenvironment. This work utilizes two tumoral acidity response groups with different response rates and highly efficient bioorthogonal click reactions, which paves a way for tumor cell ferroptosis and provides a general drug delivery strategy for enhanced tumor accumulation and penetration.
Source: europepmc · Quality: candidate unverified · Source record ↗
Research context
OpenAlex topics: Nanoplatforms for cancer theranostics · Cancer, Hypoxia, and Metabolism · Cancer Research and Treatments
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (42)
Show source-provided references
1. Hypoxia and the extracellular matrix: drivers of tumour metastasis10.1038/nrc3726 ↗
2. Hypoxia-tropic protein nanocages for modulation of tumor- and chemotherapy-associated hypoxia10.1021/acsnano.8b05399 ↗
3. Intratumoral oxygen gradients mediate sarcoma cell invasion10.1073/pnas.1605317113 ↗
4. The impact of O2 availability on human cancer10.1038/nrc2540 ↗
5. Nanomaterials to relieve tumor hypoxia for enhanced photodynamic therapy
6. Magneto-aerotactic bacteria deliver drug-containing nanoliposomes to tumour hypoxic regions10.1038/nnano.2016.137 ↗
7. Recent advances in nanostrategies capable of overcoming biological barriers for tumor management10.1002/adma.201904337 ↗
8. Innovative strategies for hypoxic-tumor photodynamic therapy10.1002/anie.201805138 ↗
9. Non-canonical glutamate-cysteine ligase activity protects against ferroptosis
10. Ferroptosis: molecular mechanisms and health implications
11. Functionalized tumor-targeting nanosheets exhibiting Fe (II) overloading and GSH consumption for ferroptosis activation in liver tumor
12. Recent progress in ferroptosis inducers for cancer therapy10.1002/adma.201904197 ↗
13. Chemodynamic Therapy: Tumour Microenvironment-Mediated Fenton And Fenton-Like Reactions10.1002/anie.201805664 ↗
14. Nanocatalysts-augmented Fenton chemical reaction for nanocatalytic tumor therapy10.1016/j.biomaterials.2019.04.023 ↗
15. Self-amplification of tumor oxidative stress with degradable metallic complexes for synergistic cascade tumor therapy10.1021/acs.nanolett.0c03127 ↗
16. Simultaneous fenton-like ion delivery and glutathione depletion by MnO2 -based nanoagent to enhance chemodynamic therapy10.1002/anie.201712027 ↗
17. Triggered all-active metal organic framework: ferroptosis machinery contributes to the apoptotic photodynamic antitumor therapy10.1021/acs.nanolett.9b02904 ↗
18. A metal-polyphenol-coordinated nanomedicine for synergistic cascade cancer chemotherapy and chemodynamic therapy10.1002/adma.201906024 ↗
19. Cinnamaldehyde induces apoptosis by ROS-mediated mitochondrial permeability transition in human promyelocytic leukemia HL-60 cells10.1016/S0304-3835(03)00238-6 ↗
20. Cascade of reactive oxygen species generation by polyprodrug for combinational photodynamic therapy10.1016/j.biomaterials.2020.120210 ↗
21. Nano-fenton reactors as a new class of oxidative stress amplifying anticancer therapeutic agents10.1021/acsami.5b12523 ↗
22. Dual acid-responsive micelle-forming anticancer polymers as new anticancer therapeutics10.1002/adfm201300871 ↗
23. Dysregulated pH: a perfect storm for cancer progression10.1038/nrc3110 ↗
24. Clearance of p16Ink4a-positive senescent cells delays ageing-associated disorders10.1038/nature10600 ↗
25. The acidic tumor microenvironment as a driver of cancer10.1146/annurev-physiol-021119-034627 ↗
26. Tumor-Acidity-Cleavable Maleic Acid Amide (TACMAA): a powerful tool for designing smart nanoparticles to overcome delivery barriers in cancer nanomedicine10.1021/acs.accounts.8b00195 ↗
27. Smart superstructures with ultrahigh pH-sensitivity for targeting acidic tumor microenvironment: instantaneous size switching and improved tumor penetration10.1021/acsnano.6b02326 ↗
28. A nanoparticle-based strategy for the imaging of a broad range of tumors by nonlinear amplification of microenvironment signals10.1038/nmat3819 ↗
29. A general strategy for macrotheranostic prodrug activation: synergy between the acidic tumor microenvironment and bioorthogonal chemistry10.1002/anie.201913522 ↗
30. Click chemistry targets antibody-drug conjugates for the clinic10.1038/d41587-019-00017-4 ↗
31. Bioorthogonal chemistry: fishing for selectivity in a sea of functionality10.1002/anie.200900942 ↗
32. Tumor-acidity and bioorthogonal chemistry-mediated on-site size transformation clustered nanosystem to overcome hypoxic resistance and enhance chemoimmunotherapy
33. Stimuli-responsive dendrimers in drug delivery10.1039/C5BM00532A ↗
34. PAMAM dendrimers as efficient drug and gene delivery nanosystems for cancer therapy10.1016/j.apmt.2018.05.002 ↗
35. Nanoparticles' interactions with vasculature in diseases10.1039/C9CS00309F ↗
36. The role of micelle size in tumor accumulation, penetration, and treatment10.1021/acsnano.5b02017 ↗
37. A tumor microenvironment responsive nanoplatform with oxidative stress amplification for effective MRI-based visual tumor ferroptosis10.1016/j.actbio.2021.11.007 ↗
38. Sequential enzyme-activated macrotheranostic probe for selective tumor mitochondria targeting10.1016/j.actbio.2021.08.002 ↗
39. Shape transformable strategies for drug delivery
40. Intercellular delivery of bioorthogonal chemical receptors for enhanced tumor targeting and penetration10.1016/j.biomaterials.2020.120298 ↗
41. Targeted ultrasound-assisted cancer-selective chemical labeling and subsequent cancer imaging using click chemistry10.1002/anie.201509601 ↗
42. Stimuli-responsive clustered nanoparticles for improved tumor penetration and therapeutic efficacy10.1073/pnas.1522080113 ↗